Also trades as: 4503.T (JPX) · $vol 92M · ALPMF (OTC) · $vol 0M

$14.32

-0.12 (-0.83%)

Weekly Expected Move ±3.8%

$13 $14 $14 $15 $15

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 44 · $25.7B mcap · 1.79B float · 0.0090% daily turnover · Short 56% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$2.27T +18.6% ▲

5Y CAGR: +12.7%

Gross Profit

$1.69T +8.2% ▲

5Y CAGR: +11.5%

Operating Income

$445.0B +984.4% ▲

5Y CAGR: +26.7%

Net Income

$309.1B +509.1% ▲

5Y CAGR: +20.7%

EPS (Diluted)

$172.56 +511.0% ▲

5Y CAGR: +21.6%

EBITDA

$651.3B +162.6% ▲

5Y CAGR: +24.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.30T	$1.52T	$1.60T	$1.91T	$2.27T
YoY Growth	+3.7%	+17.2%	+5.6%	+19.2%	+18.6%
Cost of Revenue	$281.3B	$326.8B	$292.5B	$349.2B	$577.2B
Gross Profit	$1.01T	$1.19T	$1.31T	$1.56T	$1.69T
Gross Margin	78.3%	78.5%	81.8%	81.7%	74.6%
R&D Expenses	$246.0B	$276.1B	$294.2B	$327.7B	$333.8B
SG&A Expenses	$548.8B	$630.3B	$740.1B	$843.0B	$912.2B
Operating Expenses	$794.9B	$906.4B	$1.29T	$1.52T	$1.25T
Operating Income	$155.7B	$285.4B	$25.5B	$41.0B	$445.0B
Operating Margin	12.0%	18.8%	1.6%	2.1%	19.6%
Interest Expense	$4.9B	$8.8B	$12.0B	$17.7B	$14.9B
Income Before Tax	$156.4B	$132.4B	$25.0B	$31.2B	$399.3B
Tax Expense	$32.8B	$33.6B	$7.9B	-$19.5B	$90.1B
Net Income	$124.1B	$98.7B	$17.0B	$50.7B	$309.1B
Net Margin	9.6%	6.5%	1.1%	2.7%	13.6%
EPS (Diluted)	$67.05	$54.09	$9.47	$28.24	$172.56
EBITDA	$241.5B	$246.9B	$194.8B	$248.0B	$651.3B
Shares Outstanding	1.85B	1.83B	1.80B	1.80B	1.80B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$473.1B	$462.5B	$517.4B	$459.3B	$505.8B	$533.5B	$581.5B	$647.5B
Cost of Revenue	$91.1B	$82.7B	$98.5B	$76.9B	$94.8B	$140.7B	$151.8B	$189.9B
Gross Profit	$382.0B	$379.8B	$418.9B	$382.4B	$411.0B	$392.8B	$429.7B	$457.6B
Gross Margin	80.7%	82.1%	81.0%	83.3%	81.3%	73.6%	73.9%	70.7%
R&D Expenses	$86.8B	$85.5B	$79.1B	$76.2B	$71.7B	$72.8B	$77.0B	-$221.5B
SG&A Expenses	$206.9B	$199.5B	$225.3B	$211.3B	$197.0B	$210.4B	$225.8B	$279.0B
Operating Expenses	$351.4B	$316.6B	$535.1B	$318.9B	$316.3B	$283.3B	$302.7B	$343.7B
Operating Income	$30.5B	$63.2B	-$116.2B	$63.5B	$94.6B	$109.5B	$127.0B	$113.9B
Operating Margin	6.5%	13.7%	-22.5%	13.8%	18.7%	20.5%	21.8%	17.6%
Interest Expense	$324M	$4.5B	$2.2B	$3.0B	$4.2B	$2.7B	$2.5B	$5.5B
Income Before Tax	$50.5B	$38.5B	-$118.4B	$60.6B	$90.4B	$106.0B	$136.4B	$66.5B
Tax Expense	$12.9B	$2.6B	-$20.7B	-$14.3B	$22.0B	$25.4B	$34.2B	$8.5B
Net Income	$37.6B	$35.9B	-$97.7B	$74.9B	$68.4B	$80.6B	$102.1B	$58.0B
Net Margin	7.9%	7.8%	-18.9%	16.3%	13.5%	15.1%	17.6%	9.0%
EPS (Diluted)	$20.94	$19.97	$-54.57	$41.19	$38.11	$45.00	$56.86	$32.59
EBITDA	-$67.8B	$88.0B	$126.1B	$101.8B	$151.8B	$156.9B	$188.9B	-$52.6B
Shares Outstanding	1.80B	1.80B	1.79B	1.82B	1.80B	1.80B	1.80B	1.80B

ALPMY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet